Correction: Comparative Data on Long-Term Efficacy of Biologics in Moderate-to-Severe AD: An Expert Perspective on Using Indirect Comparison Methodology Authors: Matthias Augustin, H Chih-ho Hong, Tiago Torres, Naiem T Issa Published: 2026 Correction: Dermatol Ther https://doi.org/10.1007/s13555-026-01831-w In this article, the legend for Fig. 6 is incorrect and is a duplicate of the Fig. 5 legend; the legend and figure should have appeared as shown below. Results of MAIC analyses of dupilumab and tralokinumab maintenance of efficacy across endpoints at week 32 comparing the Q2W treatment arms. Results are provided in raw format and visualized in a forest plot. CI confidence interval, EASI Eczema Area and Severity Index, EASI-75/90 ≥ 75/90% improvement in EASI from baseline, IGA Investigator Global Assessment, MAIC matching-adjusted indirect comparisons, NRS numerical rating score, pt point, Q2W every 2 weeks, RD response difference, RR response rate The original article has been corrected. Footnotes Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.